A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Management of Blood Glucose with Noninsulin Therapies in Type 2 Diabetes.
Christa M George, Lucy L Brujin, Kayley Will, Amanda Howard-Thompson. Am Fam Physician 2015
13
100

Role of glucagon-like peptide 1 receptor agonists in management of obesity.
Diana Isaacs, Lalita Prasad-Reddy, Sneha Baxi Srivastava. Am J Health Syst Pharm 2016
24
100

Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus.
Nancy J Lee, Susan L Norris, Sujata Thakurta. Ann Fam Med 2010
17
100


Liraglutide in clinical practice: dosing, safety and efficacy.
G E Peterson, R D Pollom. Int J Clin Pract Suppl 2010
22
100

Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.
Nisa M Maruthur, Eva Tseng, Susan Hutfless, Lisa M Wilson, Catalina Suarez-Cuervo, Zackary Berger, Yue Chu, Emmanuel Iyoha, Jodi B Segal, Shari Bolen. Ann Intern Med 2016
289
100

Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Srikanth Yandrapalli, George Jolly, Adam Horblitt, Abdallah Sanaani, Wilbert S Aronow. Postgrad Med 2017
28
100

The role of incretins in glucose homeostasis and diabetes treatment.
Wook Kim, Josephine M Egan. Pharmacol Rev 2008
478
100


Pramlintide in the treatment of diabetes mellitus.
Steve Edelman, Holly Maier, Ken Wilhelm. BioDrugs 2008
33
100


CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca,[...]. Endocr Pract 2018
282
100

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Amir Qaseem, Michael J Barry, Linda L Humphrey, Mary Ann Forciea, Nick Fitterman, Carrie Horwitch, Devan Kansagara, Robert M McLean, Timothy J Wilt. Ann Intern Med 2017
110
100

Empagliflozin: a sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes.
Divisha Dixit, Youngmin Yoon, Lucio R Volino, Rupal Patel Mansukhani. Am J Health Syst Pharm 2015
2
100

Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
Daniel Wolverton, Melissa M Blair. Am J Health Syst Pharm 2017
20
100


Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
Prasanth N Surampudi, Jennifer John-Kalarickal, Vivian A Fonseca. Mt Sinai J Med 2009
22
100



SGLT2 inhibitors: are they safe?
Sebastian Filippas-Ntekouan, Theodosios D Filippatos, Moses S Elisaf. Postgrad Med 2018
29
100

Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
Eu Jeong Ku, Kyong Yeon Jung, Yoon Ji Kim, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Soo Lim,[...]. PLoS One 2015
12
100

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
315
100

Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
Pascal M Mutie, Giuseppe N Giordano, Paul W Franks. BMC Med 2017
29
100


Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus.
Portia N Davis, Uche Anadu Ndefo, Ashley Oliver, Enryka Payton. Am J Health Syst Pharm 2015
6
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.